These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

832 related items for PubMed ID: 19501794

  • 1. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
    Shahid Z, Sobel JD.
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical resistance of recurrent Candida albicans vulvovaginitis to fluconazole in the presence and absence of in vitro resistance.
    MacNeill C, Weisz J, Carey JC.
    J Reprod Med; 2003 Feb; 48(2):63-8. PubMed ID: 12621787
    [Abstract] [Full Text] [Related]

  • 4. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM, Gómez D, Levalle S, Galeano M, Davel G, Vivot W, Rodero L.
    Rev Argent Microbiol; 2001 Feb; 33(4):217-22. PubMed ID: 11833253
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vulvovaginal candidiasis in a Flemish patient population.
    De Vos MM, Cuenca-Estrella M, Boekhout T, Theelen B, Matthijs N, Bauters T, Nailis H, Dhont MA, Rodriguez-Tudela JL, Nelis HJ.
    Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study.
    Lee MK, Kim HR, Kang JO, Kim MN, Kim EC, Kim JS, Kim JJ, Park YJ, Song W, Shin JH, Lee KM, Lee NY, Lee M, Lee WG, Lee CK, Lee HJ, Chang CL, Choi TY.
    Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
    Bitew A, Abebaw Y.
    BMC Womens Health; 2018 Jun 15; 18(1):94. PubMed ID: 29902998
    [Abstract] [Full Text] [Related]

  • 10. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
    Lattif AA, Mukhopadhyay G, Banerjee U, Goswami R, Prasad R.
    J Microbiol Immunol Infect; 2011 Jun 15; 44(3):166-71. PubMed ID: 21524609
    [Abstract] [Full Text] [Related]

  • 11. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A, Yacouba A, Bamba S, Sangare I, Sawadogo M, Guiguemde T, Kone S, Traore LK, Ouedraogo-Traore R, Guiguemde RT.
    J Mycol Med; 2017 Dec 15; 27(4):469-475. PubMed ID: 28754462
    [Abstract] [Full Text] [Related]

  • 12. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
    Pancholi P, Park S, Perlin D, Kubin C, Della-Latta P.
    J Clin Microbiol; 2004 Dec 15; 42(12):5938-9. PubMed ID: 15583347
    [Abstract] [Full Text] [Related]

  • 13. Fluconazole resistant non-albicans vaginal yeast in HIV seronegative women with vaginal discharge in Pune, India.
    Kairon R, Godbole S, Kulkarni S, Ghate M, Sane S, Mehendale S, Risbud A, Shrotri A, Bharucha K.
    Int J Infect Dis; 2004 Jul 15; 8(4):251-2. PubMed ID: 15234330
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole.
    Sobel JD, Kapernick PS, Zervos M, Reed BD, Hooton T, Soper D, Nyirjesy P, Heine MW, Willems J, Panzer H, Wittes H.
    Am J Obstet Gynecol; 2001 Aug 15; 185(2):363-9. PubMed ID: 11518893
    [Abstract] [Full Text] [Related]

  • 15. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H, Cao YY, Xu Z, Zhao JX, Gao PH, Qin XF, Jiang YY.
    Antimicrob Agents Chemother; 2006 Mar 15; 50(3):1096-9. PubMed ID: 16495278
    [Abstract] [Full Text] [Related]

  • 16. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis.
    Maraki S, Mavromanolaki VE, Stafylaki D, Nioti E, Hamilos G, Kasimati A.
    Mycoses; 2019 Aug 15; 62(8):692-697. PubMed ID: 31132175
    [Abstract] [Full Text] [Related]

  • 17. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis.
    Liu XP, Fan SR, Bai FY, Li J, Liao QP.
    Mycoses; 2009 Jan 15; 52(1):24-8. PubMed ID: 18498300
    [Abstract] [Full Text] [Related]

  • 18. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
    Kalkanci A, Güzel AB, Khalil II, Aydin M, Ilkit M, Kuştimur S.
    Med Mycol; 2012 Aug 15; 50(6):585-93. PubMed ID: 22369624
    [Abstract] [Full Text] [Related]

  • 19. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.
    Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, Sperling M, Livengood C, Horowitz B, Von Thron J, Edwards L, Panzer H, Chu TC.
    N Engl J Med; 2004 Aug 26; 351(9):876-83. PubMed ID: 15329425
    [Abstract] [Full Text] [Related]

  • 20. Susceptibility profile of vaginal isolates of Candida albicans prior to and following fluconazole introduction - impact of two decades.
    Bulik CC, Sobel JD, Nailor MD.
    Mycoses; 2011 Jan 26; 54(1):34-8. PubMed ID: 19563489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.